ACADIA Pharmaceuticals
ACAD
#3646
Rank
NZ$4.63 B
Marketcap
$27.80
Share price
-2.44%
Change (1 day)
-8.35%
Change (1 year)

Earnings for ACADIA Pharmaceuticals (ACAD)

Earnings in 2024 (TTM): NZ$0.44 Billion

According to ACADIA Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.95 Billion. , an increase over its 2023 earnings that were of -NZ$87.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ACADIA Pharmaceuticals from 2003 to 2024

Annual earnings

Year Earnings Change
2024 NZ$0.44 B-605.67%
2023 -NZ$87.52 Million-76.09%
2022 -NZ$0.37 Billion27.41%
2021 -NZ$0.29 Billion-40.38%
2020 -NZ$0.49 Billion19.88%
2019 -NZ$0.41 Billion-3.92%
2018 -NZ$0.42 Billion-15.04%
2017 -NZ$0.5 Billion6.33%
2016 -NZ$0.47 Billion64.55%
2015 -NZ$0.29 Billion77.47%
2014 -NZ$0.16 Billion143.69%
2013 -NZ$65.07 Million81.93%
2012 -NZ$35.77 Million-8.73%
2011 -NZ$39.19 Million-251.39%
2010 NZ$25.88 M-133.2%
2009 -NZ$77.97 Million-30.82%
2008 -NZ$0.12 Billion6.43%
2007 -NZ$0.11 Billion25.89%
2006 -NZ$84.12 Million36.99%
2005 -NZ$61.4 Million37.22%
2004 -NZ$44.75 Million19.96%
2003 -NZ$37.3 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-NZ$69.72 Million-115.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.05 B 4,206.11%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$21.74 B 4,813.46%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$29.90 B 6,658.50%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.37 Billion-3,346.73%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$66.24 Million-114.97%๐Ÿ‡บ๐Ÿ‡ธ USA